查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1701379

免疫检测市场规模、份额、趋势分析报告：按产品、技术、应用、检体、最终用途、地区和细分市场预测，2025 年至 2030 年

Immunoassay Market Size, Share & Trends Analysis Report By Product, By Technology, By Application, By Specimen, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10个工作天内

价格

免疫检测市场的成长和趋势

根据 Grand View Research, Inc. 的新报告，全球免疫检测市场规模预计到 2030 年将达到 351 亿美元，2025 年至 2030 年期间的复合年增长率为 4.59%。

PoC 快速测试和自动免疫检测分析仪的采用正在推动市场成长。此外，慢性病和感染疾病的增加也推动了市场快速成长。

根据美国癌症协会的数据，2020 年预计将有 1,690 万名癌症患者/倖存者。根据美国癌症实验室 2019 年的资料，美国约有 180 万名癌症患者被诊断出来。根据美国癌症协会的数据，2019 年约有 606,880 人死于癌症。因此，确诊癌症病例数量的增加推动了对免疫检测的需求。预计这将在未来几年推动市场成长。

此外，人们对感染疾病和预防措施的认识不断提高，导致对快速诊断测试产品的需求增加，从而促进了销售。根据世界卫生组织《2018 年世界疟疾报告》，製造商报告 2017 年横向流动化验的销售额为 2.76 亿美元。另据报导，2017 年撒哈拉以南非洲地区约 75.0% 的疟疾病例是使用横向流动化验诊断出来的。

多种基于智慧型手机的设备和相关工具已成为下一代照护现场诊断和测试设备，推动了市场成长。例如，利用智慧型手机应用程式和自主毛细管微流体晶片的组合，可以快速检测心肌梗塞中的心肌肌钙蛋白i。该平台在资源有限的环境中易于使用，并可在 12 分钟内提供测试结果。因此，预计新技术的进步将在预测期内进一步推动市场发展。

西门子医疗有限公司于2018年4月宣布在美国首次部署采用Aptio自动化技术的Atellica免疫检测解决方案，该产品旨在促进先进技术产品在美国的传播。 2020 年 12 月，丹纳赫旗下贝克曼库尔特推出了首个用于 COVID-19 抗原检测的高品质、高通量检测方法，正式命名为 Access SARS-CoV-2 抗原检测方法。 2018 年 7 月，Cygnus Technologies 和 Gyros Protein Technologies 合作生产用于识别生物治疗毒素的免疫检测。两家公司的策略合作伙伴关係将主要致力于提供生物分析解决方案和简化生物治疗製造。

免疫检测市场报告重点

  • 到2024年，套件和试剂将以66.10%的份额引领市场，这得益于个人化医疗和疾病标靶治疗需求的不断增长。然而，预计免疫检测领域的软体和服务在预测期内将以最快的复合年增长率成长，为临床和研究应用提供测试服务。
  • 免疫检测产业的感染疾病应用占据市场主导地位，占有 66.10% 的份额，预计在预测期内的复合年增长率为 5.43%。预计预测期内肿瘤学和自体免疫疾病将显着增长。
  • 受个人化医疗、癌症诊断、心血管疾病检测和感染疾病检测的推动，酵素免疫分析法吸附测定法在 2024 年的市场占有率达到 63.90%。然而，预计预测期内其他部门的复合年增长率最快。
  • 2024年，血液将占据最大的市场占有率，达到41.54%，并且是进行免疫检测的最大检体。由于尿液具有非侵入性、易于收集以及在疾病诊断中的广泛应用，预计它将成为预测期内增长最快的部分。
  • 2024年，医院在免疫检测行业的份额将达到32.54%。预计预测期内其他产业的复合年增长率为 5.45%。
  • 2024 年，北美免疫检测市场占据最大收入份额，为 47.43%，主要得益于强大的医疗保健体系、慢性病的高发病率以及对新诊断技术的日益增长的认识。受医疗改革、基础设施加强和庞大患者群的推动，亚太地区预计将实现最快的复合年增长率。

目录

第一章调查方法与范围

第二章执行摘要

第三章免疫检测市场变数、趋势与范围

  • 市场介绍/电网展望
  • 市场规模和成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 免疫检测市场分析工具
    • 波特五力分析
    • PESTEL分析

第四章免疫检测市场：按产品的估计和趋势分析

  • 免疫检测市场：产品变异分析
  • 按产品 2024 年和 2030 年
  • 检测试剂套件和试剂
    • ELISA 试剂和套件
    • 快速检测试剂和套件
    • ELISPOT 试剂与套件
    • 蛋白质印迹试剂和套件
    • 其他试剂和套件
  • 分析设备/测量仪器
    • 开放式系统
    • 封闭式系统
  • 软体和服务

第五章免疫检测市场：应用、评估与趋势分析

  • 免疫检测市场：应用变异分析
  • 按应用 2024 年和 2030 年
  • 治疗产品监测
  • 肿瘤学
  • 心臟病学
  • 内分泌学
  • 传染病检查
  • 自体免疫疾病
  • 其他的

第六章免疫检测市场：依技术进行评估与趋势分析

  • 免疫检测市场：技术变迁分析
  • 2024年和2030年的技术
  • 免疫检测（RIA）
  • 酵素免疫分析法（EIA）
    • 化学冷光免疫检测（CLIA）
    • 萤光免疫分析（FIA）
  • 快速检测
  • 其他的

第七章免疫检测市场：依检体、估计和趋势分析

  • 免疫检测市场：检体变异性分析
  • 2024 年和 2030 年的样本
  • 血
  • 唾液
  • 尿
  • 其他的

第 8 章免疫检测市场：按最终用途、估算和趋势分析

  • 免疫检测市场：最终用途变异分析
  • 依2024年及2030年的最终用途
  • 医院
  • 血库
  • 临床实验室
  • 製药和生物技术公司
  • 学术研究中心
  • 其他的

第九章免疫检测市场：区域、估计和趋势分析

  • 2024 年及 2030 年各地区免疫检测市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司热图分析
  • 公司简介
  • Abbott
  • Siemens Healthineers AG
  • Danaher Corporation（Beckman Coulter）
  • bioMerieux SA
  • Quidel Corporation
  • Sysmex Corporation
  • Ortho Clinical Diagnostics
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Becton, Dickinson, and Company
  • Thermo Fisher Scientific, Inc.
Product Code: GVR-3-68038-066-8

Immunoassay Market Growth & Trends:

The global immunoassay market size is expected to reach USD 35.10 billion by 2030, registering a CAGR of 4.59% from 2025 to 2030, according to a new report by Grand View Research, Inc. The introduction of PoC rapid tests and automated immunoassay analyzers is boosting market growth. In addition, the rising number of chronic and infectious diseases is leading to high market growth.

According to the American Cancer Society, there were an estimated 16.9 million cancer patients/survivors in 2020. Around 1.8 million cancer cases were diagnosed in the U.S., according to the National Cancer Institute 2019 data. According to the American Cancer Society, nearly 606,880 deaths occurred due to cancer in the U.S. in 2019. Thus, the rise in the number of cancer cases being diagnosed is driving the demand for immunoassays. This is expected to boost the market growth in the coming years.

Furthermore, growing awareness regarding infectious diseases and preventive measures has led to a high demand for rapid diagnostic test products, thereby increasing sales. Based on a survey by the WHO on the World malaria report 2018, manufacturers reported sales of 276 million for lateral flow assays in 2017. It also reported that around 75.0% of malaria cases were diagnosed using lateral flow assays in sub-Saharan Africa in 2017.

Several smartphone-based devices and associated tools have emerged as next-generation point-of-care diagnostics or testing devices, thereby boosting the market growth. For instance, a smartphone application combined with the autonomous capillary microfluidic chip is used for the rapid testing of cardiac troponin I in myocardial infarction. This platform can be easily used in resource-limited settings, providing test results within 12 minutes. Thus, novel technological advancements are anticipated to further drive the market over the forecast period.

The first implementation of the Atellica immunoassay solutions with Aptio automation in the United States was announced by Siemens Healthcare GmbH in April 2018. The objective of this product was designed to promote advanced technological products in the U.S. In December 2020, Beckman Coulter, a Danaher business, introduced its first high-quality as well as throughput assay for the COVID-19 antigen detection, officially named Access SARS-CoV-2 Antigen assay. In July 2018, Cygnus Technologies and Gyros Protein Technologies collaborated to produce immunoassay to identify biotherapeutic toxins. The two companies' strategic alliance will primarily focus on offering bioanalytical solutions and increasing biotherapeutics manufacturing efficiencies.

Immunoassay Market Report Highlights:

  • In 2024, kits and reagents led the market with a 66.10% share, driven by increasing demand for personalized medicine and targeted therapies for diseases. However, the software and services of the immunoassays segment is projected to grow at the fastest CAGR during the forecast period and are delivering testing services for clinical and research uses.
  • The infectious disease application in the immunoassay industry led the market with a 66.10% share and is expected to grow at a CAGR of 5.43% over the forecast period. Oncology and autoimmune diseases are projected to grow at a significant growth during the forecast period.
  • Enzyme immunoassays secured the dominant market share in 2024 of 63.90% focusing on personalized medicine, cancer diagnostics, cardiovascular disease testing, and infectious disease detection. However, the others segment is projected to grow at the fastest CAGR during the forecast period.
  • Blood held the largest market share of 41.54% in 2024, being the largest specimen used for performing immunoassays. Urine is expected to be the fastest-growing segment over the forecast period, driven by its non-invasive nature, ease of collection, and widespread application in disease diagnostics.
  • In 2024, the hospitals in the immunoassay industry held a 32.54% share. Others are projected to grow at a CAGR of 5.45% during the forecast period.
  • North America immunoassay market held the largest revenue share at 47.43% in 2024, primarily supported by robust healthcare systems, a high incidence of chronic illnesses, and a growing awareness of new diagnostic technologies. Asia Pacific is set to record the fastest CAGR, propelled by healthcare reforms, infrastructure enhancements, and a large patient pool.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Immunoassay Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Rising incidence of chronic and infectious diseases
      • 3.3.1.2. Increasing demand for point-of-care diagnostics
      • 3.3.1.3. Growing demand for portable and automated immunoassays
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. Lower detection limit
      • 3.3.2.2. Limitations associated with immunoassay techniques
  • 3.4. Immunoassay Market Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Immunoassay Market: Product Estimates & Trend Analysis

  • 4.1. Immunoassay Market: Product Movement Analysis
  • 4.2. Immunoassay Market Estimates and Forecasts, by Product 2024 & 2030 (USD Million)
  • 4.3. Assays, Kits, and Reagents
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. ELISA Reagents & Kits
      • 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Rapid Tests Reagents & Kits
      • 4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. ELISPOT Reagents & Kits
      • 4.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Western Blot Reagents & Kits
      • 4.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.6. Other Reagents & Kits
      • 4.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Analyzers/Instruments
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Open Ended Systems
      • 4.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Closed Ended Systems
      • 4.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Software and Services
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Immunoassay Market: Application Estimates & Trend Analysis

  • 5.1. Immunoassay Market: Application Movement Analysis
  • 5.2. Immunoassay Market Estimates and Forecasts, by Application 2024 & 2030 (USD Million)
  • 5.3. Therapeutic Drug Monitoring
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cardiology
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Endocrinology
    • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Infectious Disease Testing
    • 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Autoimmune Diseases
    • 5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Immunoassay Market: Technology Estimates & Trend Analysis

  • 6.1. Immunoassay Market: Technology Movement Analysis
  • 6.2. Immunoassay Market Estimates and Forecasts, by Technology 2024 & 2030 (USD Million)
  • 6.3. Radioimmunoassay (RIA)
    • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Enzyme Immunoassays (EIA)
    • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Chemiluminescence Immunoassays (CLIA)
      • 6.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Fluorescence Immunoassays (FIA)
      • 6.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Rapid Test
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Immunoassay Market: Specimen Estimates & Trend Analysis

  • 7.1. Immunoassay Market: Specimen Movement Analysis
  • 7.2. Immunoassay Market Estimates and Forecasts, by Specimen 2024 & 2030 (USD Million)
  • 7.3. Blood
    • 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Saliva
    • 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Urine
    • 7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Immunoassay Market: End Use Estimates & Trend Analysis

  • 8.1. Immunoassay Market: End--use Movement Analysis
  • 8.2. Immunoassay Market Estimates and Forecasts, by End-use 2024 & 2030 (USD Million)
  • 8.3. Hospitals
    • 8.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Blood Banks
    • 8.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Clinical Laboratories
    • 8.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Pharmaceutical and Biotech Companies
    • 8.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Academic Research Centers
    • 8.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Others
    • 8.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Immunoassay Market: Regional Estimates & Trend Analysis

  • 9.1. Immunoassay Market Share, By Region, 2024 & 2030 (USD Million)
  • 9.2. North America
    • 9.2.1. North America Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Target Disease Prevalence
      • 9.2.2.3. Competitive Scenario
      • 9.2.2.4. Regulatory Framework
      • 9.2.2.5. Reimbursement Scenario
      • 9.2.2.6. U.S. Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Target Disease Prevalence
      • 9.2.3.3. Competitive Scenario
      • 9.2.3.4. Regulatory Framework
      • 9.2.3.5. Reimbursement Scenario
      • 9.2.3.6. Canada Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Target Disease Prevalence
      • 9.2.4.3. Competitive Scenario
      • 9.2.4.4. Regulatory Framework
      • 9.2.4.5. Reimbursement Scenario
      • 9.2.4.6. Mexico Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. Reimbursement Scenario
      • 9.3.2.6. UK Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. Germany Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. France Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Target Disease Prevalence
      • 9.3.5.3. Competitive Scenario
      • 9.3.5.4. Regulatory Framework
      • 9.3.5.5. Reimbursement Scenario
      • 9.3.5.6. Italy Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Target Disease Prevalence
      • 9.3.6.3. Competitive Scenario
      • 9.3.6.4. Regulatory Framework
      • 9.3.6.5. Reimbursement Scenario
      • 9.3.6.6. Spain Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Target Disease Prevalence
      • 9.3.7.3. Competitive Scenario
      • 9.3.7.4. Regulatory Framework
      • 9.3.7.5. Reimbursement Scenario
      • 9.3.7.6. Denmark Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Target Disease Prevalence
      • 9.3.8.3. Competitive Scenario
      • 9.3.8.4. Regulatory Framework
      • 9.3.8.5. Reimbursement Scenario
      • 9.3.8.6. Sweden Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Target Disease Prevalence
      • 9.3.9.3. Competitive Scenario
      • 9.3.9.4. Regulatory Framework
      • 9.3.9.5. Reimbursement Scenario
      • 9.3.9.6. Norway Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. Reimbursement Scenario
      • 9.4.2.6. Japan Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. China Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. India Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. Australia Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. South Korea Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Thailand Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Reimbursement Scenario
      • 9.5.2.6. Brazil Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. Argentina Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Reimbursement Scenario
      • 9.6.2.6. South Africa Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. Saudi Arabia Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Prevalence
      • 9.6.4.3. Competitive Scenario
      • 9.6.4.4. Regulatory Framework
      • 9.6.4.5. Reimbursement Scenario
      • 9.6.4.6. UAE Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Prevalence
      • 9.6.5.3. Competitive Scenario
      • 9.6.5.4. Regulatory Framework
      • 9.6.5.5. Reimbursement Scenario
      • 9.6.5.6. Kuwait Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Heat Map Analysis
  • 10.4. Company Profiles
  • 10.5. Abbott
    • 10.5.1. Participant's Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Developments/ Strategic Initiatives
  • 10.6. Siemens Healthineers AG
    • 10.6.1. Participant's Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Developments/ Strategic Initiatives
  • 10.7. Danaher Corporation (Beckman Coulter)
    • 10.7.1. Participant's Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Developments/ Strategic Initiatives
  • 10.8. bioMerieux SA
    • 10.8.1. Participant's Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Developments/ Strategic Initiatives
  • 10.9. Quidel Corporation
    • 10.9.1. Participant's Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Developments/ Strategic Initiatives
  • 10.10. Sysmex Corporation
    • 10.10.1. Participant's Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Developments/ Strategic Initiatives
  • 10.11. Ortho Clinical Diagnostics
    • 10.11.1. Participant's Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Developments/ Strategic Initiatives
  • 10.12. Bio-Rad Laboratories, Inc.
    • 10.12.1. Participant's Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Developments/ Strategic Initiatives
  • 10.13. F. Hoffmann-La Roche AG
    • 10.13.1. Participant's Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Developments/ Strategic Initiatives
  • 10.14. Becton, Dickinson, and Company
    • 10.14.1. Participant's Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Developments/ Strategic Initiatives
  • 10.15. Thermo Fisher Scientific, Inc.
    • 10.15.1. Participant's Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global immunoassay market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 7 Global immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 North America immunoassay market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 10 North America immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 12 North America immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 13 North America immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 16 U.S. immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 17 U.S. immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 18 U.S. immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Canada immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 20 Canada immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 21 Canada immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Canada immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 23 Canada immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Mexico immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 25 Mexico immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 26 Mexico immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Mexico immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 28 Mexico immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Europe immunoassay market, by country, 2018 - 2030 (USD Million)
  • Table 30 Europe immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 31 Europe immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 32 Europe immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Europe immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 34 Europe immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 UK immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 36 UK immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 37 UK immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 38 UK immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 39 UK immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Germany immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 41 Germany immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 42 Germany immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Germany immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 44 Germany immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 France immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 46 France immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 47 France immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 48 France immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 49 France immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Italy immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 51 Italy immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 52 Italy immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Italy immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 54 Italy immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Spain immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 56 Spain immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 57 Spain immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Spain immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 59 Spain immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Denmark immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 61 Denmark immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 62 Denmark immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Denmark immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 64 Denmark immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Sweden immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 66 Sweden immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 67 Sweden immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Sweden immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 69 Sweden immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Norway immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 71 Norway immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 72 Norway immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 73 Norway immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 74 Norway immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific immunoassay market, by country, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Japan immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 82 Japan immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 83 Japan immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Japan immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 85 Japan immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 China immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 87 China immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 88 China immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 89 China immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 90 China immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 India immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 92 India immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 93 India immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 94 India immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 95 India immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 Australia immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 97 Australia immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 98 Australia immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 99 Australia immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 100 Australia immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 101 South Korea immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 102 South Korea immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 103 South Korea immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 104 South Korea immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 105 South Korea immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 106 Thailand immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 107 Thailand immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 108 Thailand immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Thailand immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 110 Thailand immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 Latin America immunoassay market, by country, 2018 - 2030 (USD Million)
  • Table 112 Latin America immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 113 Latin America immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 114 Latin America immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 115 Latin America immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 116 Latin America immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 117 Brazil immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 118 Brazil immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 119 Brazil immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 120 Brazil immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 121 Brazil immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 122 Argentina immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 123 Argentina immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 124 Argentina immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 125 Argentina immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 126 Argentina immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 127 MEA immunoassay market, by country, 2018 - 2030 (USD Million)
  • Table 128 MEA immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 129 MEA immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 130 MEA immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 131 MEA immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 132 MEA immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 133 South Africa immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 134 South Africa immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 135 South Africa immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 136 South Africa immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 137 South Africa immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 143 UAE immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 144 UAE immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 145 UAE immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 146 UAE immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 147 UAE immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 149 Kuwait immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 150 Kuwait immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 151 Kuwait immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 152 Kuwait immunoassay market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Immunoassay market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Immunoassay market: Product outlook key takeaways
  • Fig. 20 Immunoassay market: Product movement analysis
  • Fig. 21 Assays, kits, and reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 ELISA Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Rapid Tests Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 ELISPOT Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Western Blot Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Other Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Analyzers/Instruments and systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Software and services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Open Ended Systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Closed Ended Systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Immunoassay market: Application outlook key takeaways
  • Fig. 32 Immunoassay market: Application movement analysis
  • Fig. 33 Therapeutic Drug Monitoring
  • Fig. 34 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Endocrinology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Infectious Disease Testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Autoimmune Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Immunoassay market: Technology outlook key takeaways
  • Fig. 41 Immunoassay market: Technology movement analysis
  • Fig. 42 Radioimmunoassay (RIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Enzyme Immunoassays (EIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Rapid Test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Chemiluminescence Immunoassays (CLIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Fluorescence Immunoassays (FIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Immunoassay market: Specimen outlook key takeaways
  • Fig. 49 Immunoassay market: Specimen movement analysis
  • Fig. 50 Blood market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Saliva market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Urine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Immunoassay market: End-use outlook key takeaways
  • Fig. 55 Immunoassay market: End-use movement analysis
  • Fig. 56 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Blood Banks market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Clinical Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Pharmaceutical and Biotech Companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Academic Research Centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Regional marketplace outlook, 2024 & 2030 (USD Million)
  • Fig. 63 Regional marketplace: Key takeaways
  • Fig. 64 North America immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 U.S. immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Canada immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Mexico immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Europe immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 UK immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Germany immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 France immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Spain immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Italy immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Denmark immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Sweden immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Norway immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Asia Pacific immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Japan immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 China immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 India immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Australia immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 South Korea immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Thailand immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Market participant categorization
  • Fig. 103 Immunoassay market position analysis, 2023
  • Fig. 104 Strategic framework